These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 30413008

  • 1. Antiproliferative Activity of Combined Biochanin A and Ginsenoside Rh₂ on MDA-MB-231 and MCF-7 Human Breast Cancer Cells.
    Ren G, Shi Z, Teng C, Yao Y.
    Molecules; 2018 Nov 08; 23(11):. PubMed ID: 30413008
    [Abstract] [Full Text] [Related]

  • 2. Ginsenoside Rh2 Ameliorates Doxorubicin-Induced Senescence Bystander Effect in Breast Carcinoma Cell MDA-MB-231 and Normal Epithelial Cell MCF-10A.
    Hou JG, Jeon BM, Yun YJ, Cui CH, Kim SC.
    Int J Mol Sci; 2019 Mar 12; 20(5):. PubMed ID: 30871042
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Genistein-induced apoptosis of human breast cancer MCF-7 cells involves calpain-caspase and apoptosis signaling kinase 1-p38 mitogen-activated protein kinase activation cascades.
    Shim HY, Park JH, Paik HD, Nah SY, Kim DS, Han YS.
    Anticancer Drugs; 2007 Jul 12; 18(6):649-57. PubMed ID: 17762393
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Growth and molecular interactions of the anti-EGFR antibody cetuximab and the DNA cross-linking agent cisplatin in gefitinib-resistant MDA-MB-468 cells: new prospects in the treatment of triple-negative/basal-like breast cancer.
    Oliveras-Ferraros C, Vazquez-Martin A, López-Bonet E, Martín-Castillo B, Del Barco S, Brunet J, Menendez JA.
    Int J Oncol; 2008 Dec 12; 33(6):1165-76. PubMed ID: 19020749
    [Abstract] [Full Text] [Related]

  • 10. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
    Li JP, Yang YX, Liu QL, Pan ST, He ZX, Zhang X, Yang T, Chen XW, Wang D, Qiu JX, Zhou SF.
    Drug Des Devel Ther; 2015 Dec 12; 9():1627-52. PubMed ID: 25834401
    [Abstract] [Full Text] [Related]

  • 11. 2α-Hydroxyursolic Acid Inhibited Cell Proliferation and Induced Apoptosis in MDA-MB-231 Human Breast Cancer Cells through the p38/MAPK Signal Transduction Pathway.
    Jiang X, Li T, Liu RH.
    J Agric Food Chem; 2016 Mar 02; 64(8):1806-16. PubMed ID: 26872218
    [Abstract] [Full Text] [Related]

  • 12. A triterpenoid from wild bitter gourd inhibits breast cancer cells.
    Bai LY, Chiu CF, Chu PC, Lin WY, Chiu SJ, Weng JR.
    Sci Rep; 2016 Mar 01; 6():22419. PubMed ID: 26926586
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Phytoestrogens induce apoptosis via extrinsic pathway, inhibiting nuclear factor-kappaB signaling in HER2-overexpressing breast cancer cells.
    Seo HS, Choi HS, Choi HS, Choi YK, Um JY, Choi I, Shin YC, Ko SG.
    Anticancer Res; 2011 Oct 01; 31(10):3301-13. PubMed ID: 21965740
    [Abstract] [Full Text] [Related]

  • 15. Effect of recombinant human erythropoietin and doxorubicin in combination on the proliferation of MCF-7 and MDA-MB231 breast cancer cells.
    Radwan EM, Abdullah R, Al-Qubaisi MS, El Zowalaty ME, Naadja SE, Alitheen NB, Omar AR.
    Mol Med Rep; 2016 May 01; 13(5):3945-52. PubMed ID: 26987078
    [Abstract] [Full Text] [Related]

  • 16. Cellular effect of styrene substituted biscoumarin caused cellular apoptosis and cell cycle arrest in human breast cancer cells.
    Perumalsamy H, Sankarapandian K, Kandaswamy N, Balusamy SR, Periyathambi D, Raveendiran N.
    Int J Biochem Cell Biol; 2017 Nov 01; 92():104-114. PubMed ID: 28958615
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Lapatinib sensitizes quiescent MDA-MB-231 breast cancer cells to doxorubicin by inhibiting the expression of multidrug resistance-associated protein-1.
    Kwon YS, Chun SY, Nam KS, Kim S.
    Oncol Rep; 2015 Aug 01; 34(2):884-90. PubMed ID: 26063481
    [Abstract] [Full Text] [Related]

  • 19. The immunomodulatory drug lenalidomide restores a vitamin D sensitive phenotype to the vitamin D resistant breast cancer cell line MDA-MB-231 through inhibition of BCL-2: potential for breast cancer therapeutics.
    Brosseau C, Colston K, Dalgleish AG, Galustian C.
    Apoptosis; 2012 Feb 01; 17(2):164-73. PubMed ID: 22109882
    [Abstract] [Full Text] [Related]

  • 20. Down-regulation of cyclin-dependent kinase-4 and MAPK through estrogen receptor mediated cell cycle arrest in human breast cancer induced by gold nanoparticle tagged toxin protein NKCT1.
    Bhowmik T, Gomes A.
    Chem Biol Interact; 2017 Apr 25; 268():119-128. PubMed ID: 28322778
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.